Dare Bioscience (DARE) Halted, News Pending
- Dow closes lower after disappointing bank results
- JPMorgan (JPM) Stock Falls 5% After Q4 Results, Top-Line Beats but 2022 Expense Outlook Disappoint, Analyst Expects Rising Wage Inflation to be a Key Earnings Theme
- Netflix raises monthly subscription prices in U.S., Canada
- Apple (AAPL) Stock Receives Three Price Targets Hikes Today, Wedbush Positive on Live Sports Content Opportunity
- Wells Fargo (WFC) Tops Street Estimates, Profit Fueled by Loan Demand and Cost Cuts
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Dare Bioscience (NASDAQ: DARE) Halted, News Pending
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CI&T Inc (CINT) to acquire Somo Global
- Peloton (PTON) Slipping Lower Pre-Market Following Stock's Removal from Nasdaq 100 Index
- Field Trip Health (FTRP) Halted, News Pending
Create E-mail Alert Related CategoriesTrading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!